ZTS | Zoetis Inc.

IndexS&P 500 P/E36.83 EPS (ttm)4.43 Insider Own0.20% Shs Outstand463.50M Perf Week-5.11%
Market Cap72.79B Forward P/E26.82 EPS next Y6.08 Insider Trans-3.29% Shs Float461.18M Perf Month-11.91%
Income2.07B PEG3.32 EPS next Q1.31 Inst Own94.50% Short Float / Ratio0.80% / 1.86 Perf Quarter0.97%
Sales8.09B P/S8.99 EPS this Y5.20% Inst Trans0.02% Short Interest3.71M Perf Half Y8.55%
Book/sh9.70 P/B16.81 EPS next Y12.57% ROA14.80% Target Price215.08 Perf Year-4.79%
Cash/sh4.72 P/C34.58 EPS next 5Y11.10% ROE45.70% 52W Range124.15 - 187.82 Perf YTD11.29%
Dividend1.50 P/FCF88.01 EPS past 5Y15.50% ROI17.20% 52W High-13.17% Beta0.77
Dividend %0.92% Quick Ratio1.90 Sales past 5Y8.80% Gross Margin69.90% 52W Low31.37% ATR4.10
Employees13800 Current Ratio3.30 Sales Q/Q0.70% Oper. Margin32.40% RSI (14)36.73 Volatility2.11% 2.28%
OptionableYes Debt/Eq1.46 EPS Q/Q-5.30% Profit Margin25.60% Rel Volume0.68 Prev Close164.30
ShortableYes LT Debt/Eq1.46 EarningsMay 04 BMO Payout30.40% Avg Volume1.99M Price163.09
Recom1.70 SMA20-5.58% SMA50-6.07% SMA2001.73% Volume1,346,568 Change-0.74%
Date Action Analyst Rating Change Price Target Change
Jul-12-22Initiated Piper Sandler Overweight $205
Nov-18-21Initiated Morgan Stanley Overweight $40
Nov-18-21Initiated Morgan Stanley Overweight $264
Aug-05-21Resumed Credit Suisse Outperform $206
Jul-16-21Downgrade Raymond James Outperform → Mkt Perform
Mar-08-21Upgrade Raymond James Mkt Perform → Outperform $166
Mar-08-21Upgrade BofA Securities Neutral → Buy $180
Sep-21-20Initiated Atlantic Equities Overweight $191
Aug-14-20Upgrade Edward Jones Hold → Buy
Aug-12-20Downgrade Gabelli & Co Buy → Hold
Jun-09-23 06:15PM
09:00AM
Jun-04-23 10:00AM
May-30-23 04:30PM
May-25-23 07:30AM
05:19AM Loading…
May-18-23 05:19AM
May-15-23 09:24AM
May-12-23 02:10PM
May-11-23 04:05PM
08:58AM
May-09-23 10:22AM
May-05-23 03:44PM
May-04-23 11:16PM
04:06PM
02:59PM
12:30PM Loading…
12:30PM
12:04PM
11:17AM
09:30AM
09:27AM
08:25AM
07:35AM
07:00AM
May-03-23 11:46AM
08:48AM
May-02-23 06:15PM
May-01-23 08:30AM
06:20AM
Apr-30-23 05:09AM
Apr-28-23 10:07AM
10:00AM Loading…
10:00AM
Apr-27-23 06:15PM
10:02AM
Apr-24-23 02:35PM
Apr-21-23 06:15PM
Apr-18-23 11:40AM
09:27AM
Apr-17-23 04:49PM
Apr-14-23 05:11PM
10:49AM
10:00AM
Apr-10-23 06:00PM
Apr-08-23 09:48AM
Apr-05-23 08:00AM
Apr-03-23 07:24AM
07:09AM
Mar-31-23 10:37AM
Mar-30-23 08:30AM
Mar-29-23 09:36AM
01:00AM
Mar-27-23 04:00PM
Mar-17-23 06:15PM
08:20AM
Mar-16-23 04:26PM
11:30AM
Mar-13-23 08:00AM
Mar-03-23 08:30AM
Mar-01-23 11:40AM
07:00AM
06:30AM
Feb-28-23 08:30AM
Feb-27-23 07:56AM
Feb-17-23 05:24PM
02:02PM
11:32AM
Feb-15-23 03:43PM
Feb-14-23 04:08PM
03:34PM
02:30PM
11:57AM
11:17AM
11:12AM
10:48AM
09:11AM
08:32AM
08:22AM
08:15AM
07:00AM
Feb-13-23 11:40AM
08:15AM
Feb-11-23 09:00AM
Feb-10-23 08:37AM
Feb-09-23 06:15PM
Feb-08-23 04:10PM
Feb-07-23 10:00AM
Feb-02-23 06:15PM
Jan-28-23 10:15AM
Jan-27-23 06:15PM
11:40AM
Jan-19-23 12:55PM
Jan-18-23 10:15AM
Jan-17-23 09:37AM
Jan-12-23 06:59PM
01:25PM
01:10PM
Jan-11-23 04:52PM
11:40AM
09:45AM
Jan-05-23 08:37AM
Jan-03-23 02:26PM
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PECK KRISTIN CChief Executive OfficerMay 23Option Exercise41.8313,000543,79069,843May 25 04:13 PM
PECK KRISTIN CChief Executive OfficerMay 23Sale176.5613,0002,295,33556,843May 25 04:13 PM
Lagano RoxanneExecutive Vice PresidentApr 18Option Exercise79.854,338346,39830,695Apr 19 04:18 PM
Lagano RoxanneExecutive Vice PresidentApr 18Sale175.944,338763,22826,357Apr 19 04:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 14Option Exercise79.8513,0101,038,84339,367Feb 16 04:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 14Sale175.0013,0102,276,75026,357Feb 16 04:18 PM
Lagano RoxanneExecutive Vice PresidentJul 22Option Exercise79.852,167173,03825,854Jul 26 04:36 PM
Lagano RoxanneExecutive Vice PresidentJul 22Sale180.262,167390,62323,687Jul 26 04:36 PM
PECK KRISTIN CChief Executive OfficerJul 21Option Exercise36.499,689353,59949,432Jul 25 04:08 PM
PECK KRISTIN CChief Executive OfficerJul 21Sale180.009,6891,744,02039,743Jul 25 04:08 PM
PECK KRISTIN CChief Executive OfficerJul 07Option Exercise30.893119,60740,054Jul 11 04:08 PM
PECK KRISTIN CChief Executive OfficerJul 07Sale180.0031155,98039,743Jul 11 04:08 PM
Lagano RoxanneExecutive Vice PresidentJun 27Option Exercise79.854,334346,07628,021Jun 28 05:29 PM
Lagano RoxanneExecutive Vice PresidentJun 27Sale175.004,334758,45023,687Jun 28 05:29 PM